NCT04387786View on ClinicalTrials.gov

Dornase Alfa Administered to Patients With COVID-19 (DACOVID)

CompletedOBSERVATIONAL
Enrollment

5

Participants

Timeline

Start Date

March 31, 2020

Primary Completion Date

April 24, 2020

Study Completion Date

September 4, 2020

Conditions
COVID-19Mechanical Ventilation
Interventions
DRUG

Dornase Alfa

nebulized in-line endotracheal dornase alfa co-administered with albuterol

Trial Locations (1)

11030

Feinstein Insitute for Medical Research at Northwell Health, Manhasset

Sponsors
All Listed Sponsors
collaborator

Cold Spring Harbor Laboratory

OTHER

lead

Feinstein Institute for Medical Research

OTHER